Insight Molecular Diagnostics Inc. (OCX)

Profile

https://www.imdxinc.com

Insight Molecular Diagnostics Inc. is a molecular diagnostics company focused on precision testing for transplantation and oncology. The company develops and commercializes laboratory-developed, kitted research-use, and clinical diagnostic tests that help clinicians assess organ rejection, monitor therapeutic response, and characterize tumor biology. Its current portfolio includes GraftAssure, a blood-based platform for transplanted organ health monitoring, along with oncology assays such as DetermaIO and DetermaCNI. Insight Molecular Diagnostics also supports researchers, pharmaceutical customers, and healthcare systems with molecular diagnostic services and precision medicine solutions. Headquartered in Nashville, Tennessee, the company operates a clinical laboratory that serves U.S. medical and research markets.